Insider · CIK 0001763511
Elsbernd Brian
officer
Files at CPRX (CATALYST PHARMACEUTICALS, INC.). First filing Nov 29, 2024, latest Nov 29, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $287k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 29Weak | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | $287k | 13,256 | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 183,191 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | FTax withholding Common Stock, par value $0.001 per share | -1,941 | - | - | 181,250 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 1,081,276 | Dec 31, 2024 |
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common Stock, par value $0.001 per share | +7,067 | - | - | 178,244 | Dec 11, 2024 |
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | FTax withholding Common Stock, par value $0.001 per share | -1,720 | - | - | 176,524 | Dec 11, 2024 |
| Dec 9, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -7,067 | $0.00 | $0 | 1,087,943 | Dec 11, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common Stock, par value $0.001 per share | +50,244 | $4.01 | $201k | 174,677 | Nov 29, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common Stock, par value $0.001 per share | -9,300 | $21.65 | $201k | 165,377 | Nov 29, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Common Stock, par value $0.001 per share | +9,756 | $4.01 | $39k | 175,133 | Nov 29, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | SOpen-market sale Common Stock, par value $0.001 per share | -3,956 | $21.58 | $85k | 171,177 | Nov 29, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to Purchase Common Stockderivative | -50,244 | $0.00 | $0 | 1,104,766 | Nov 29, 2024 |
| Nov 26, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | MOption exercise Options to Purchase Common Stockderivative | -9,756 | $0.00 | $0 | 1,095,010 | Nov 29, 2024 |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Options to purchase common stockderivative | +126,704 | $0.00 | $0 | 1,139,527 | Nov 25, 2024 |
| Nov 21, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +15,483 | $0.00 | $0 | 1,155,010 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.